Clinical Reference Laboratory Testing Services - Government Response to DRAFT RFP Q&As
Closed Special Notice Posted
Not the latest version. See the latest solicitation from .
- Agency
-
Defense Health Agency
Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Place of performance
- United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Health Agency has issued a Special Notice on March 19, 2026, providing government responses to industry questions and feedback regarding Draft RFP HT001526RE001 for Clinical Reference Laboratory Testing Services. This notice addresses 21 substantive questions that were submitted by potential contractors following the initial draft RFP posting on February 20, 2026. The responses clarify critical requirements, evaluation methodology, technical specifications, and operational parameters for the clinical laboratory testing procurement. The document serves to provide necessary guidance during the draft solicitation phase to enable industry stakeholders to better understand the government's expectations and intent for the final RFP. Responses are contained in an attached Excel file that represents the authoritative source for these clarifications. The due date for responding to this special notice is March 20, 2026.
The primary purpose of this special notice is to clarify ambiguities and address concerns raised by industry regarding the draft RFP before the final solicitation is issued. Key requirements include a mandatory 3% total small business participation, compliance with CLIA certification standards, and the ability to meet a 3-hour STAT courier pickup requirement across all Defense or Health Agency sites, including overseas locations. The government will evaluate proposals using a best-value tradeoff approach based on technical acceptability, past and present performance as the primary differentiator, and pricing, with a minimum font size of 11-point throughout all proposal volumes. Eligible contractors must include CLIA-certified laboratories and may utilize CLIA-certified specialty or reference laboratories as subcontractors for advanced molecular diagnostics and esoteric testing. The solicitation requires industry-standard HL7 interfaces for electronic data integration with MHS Genesis, and New York State Department of Health licenses are mandatory where applicable for laboratories processing New York specimens. The estimated contract workload is approximately 1,799,616 total test units annually across all testing categories.
Notice text
The Government has provided responses to the questions and feedback from industry in response to the DRAFT RFP HT001526RE001 - Clinical Reference Laboratory Testing Services Exhibit B - Q&A posted on 20 February 2026.
Please see the attached document - DRAFT RFP HT001526RE001 - QandA - Government Response
Files
| File | Type | Posted |
|---|---|---|
| DRAFT RFP HT001526RE001 - QandA - Government Response.xlsx | XLSX spreadsheet |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Clinical Reference Laboratory Testing Services | Solicitation | |
| Clinical Reference Laboratory Testing Services | Solicitation | |
| Clinical Reference Laboratory Testing Services | Special Notice | |
| Clinical Reference Laboratory Testing Services | Pre-Solicitation | |
| Clinical Reference Laboratory Testing Services - Government Response to DRAFT RFP Q&As | Special Notice | |
| This notice | Special Notice | |
| Clinical Reference Laboratory Testing Services | Pre-Solicitation | |
| Clinical Reference Laboratory Testing Services | Special Notice |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity